Dear Editor,
We routinely do bursectomy for radical gastrectomy for gastric cancers to remove the tumor cells on the bursa omentalis. However, we have some doubts about its effectiveness, and there have been some studies about the impossibility of eliminating migrated tumor cells in the peritoneal cavity [1] . We wanted to test the procedure by sending bursectomy specimens (anterior layer of the mesocolon and the pancreas) of 40 gastric cancer patients separately for pathological examination. We additionally examined the cytology of bursa omentalis wash-out of those patients. Only four bursectomy specimens (10%) demonstrated positive cancer cells, and all already had macroscopic tumors on the peritoneal surfaces of the transverse mesocolon or pancreas. The remaining 36 bursectomy specimens were removed as a prophylactic procedure, and none resulted in positive pathological results. The cytology of bursa omentalis wash-out results was generally parallel to these pathological reports. Despite these observations, we have not changed our routine bursectomy protocol yet, and recently we read the article of Fujita et al. about the ''Survival benefit of bursectomy in patients with resectable gastric cancer: interim analysis results of a randomized controlled trial'' in Gastric Cancer [1] . We have some questions and comments about this article.
In this study, 77% of the tumors did not invade the serosa. If the Japanese Gastric Cancer Association recommends bursectomy for tumors with invasion to the serosa [2, 3] , why did the authors include T 2 tumors in this study? Only 48 patients (including 23 and 25 patients in each group) had T 3-4 stages, and the mean conclusion (survival benefit with bursectomy) was based on this limited number of cases. As the authors mentioned before [3] , the power analysis of this study required at least 200 cases to draw a clear conclusion. Did the authors find the number of T 3-4 cases sufficient to reach a clear conclusion? In general, the authors found no difference in the baseline characteristics of either group. What about the baseline characteristics of the serosa-invaded patients of both the bursectomy and non-bursectomy groups? Were they comparable or not? As the authors mentioned in their previous article including the early results [2] , the risk of intestinal obstruction should have required careful observation, particularly in the bursectomy group. Was there any increased risk of intestinal obstruction at the late follow-up period? The study included a wide spectrum of gastric cancers from T 2 N 0 to T 3-4 N 2-3 patients. Although there were no differences between the groups for T and N stages separately, was there any difference among the bursectomy and non-bursectomy groups related with TNM stages?
